United States
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • CH
    • DK
    • PL
    • UK
  • News
  • US
  • World
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health
  • States
  • @
  • Artificial intelligence
  • Arts and design
  • Books
  • Business
  • Celebrities
  • Chicago
  • Computing
  • Dallas
  • Diesel
  • Economy
  • Entertainment
  • Entrepreneurship
  • Environment
  • Fitness
  • Fort Worth
  • Gadgets
  • Gas
  • Genetics
  • Golf
  • Health
  • Health care
  • Houston
  • Internet
  • Jacksonville
  • Jobs
  • Los Angeles
  • Markets
  • Medication
  • Mental health
  • MLB
  • Mobile
  • Movies
  • Music
  • NASCAR
  • NBA
  • NCAA Basketball
  • NCAA Football
  • New York
  • News
  • NFL
  • NHL
  • Nutrition
  • Personal finance
  • Philadelphia
  • Phoenix
  • Physics
  • San Antonio
  • San Diego
  • Science
  • Soccer
  • Space
  • Sports
  • Technology
  • Tennis
  • TV
  • United States
  • US
  • Virtual reality
  • Wildlife
  • WNBA
  • World
United States
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • CH
    • DK
    • PL
    • UK
  • News
  • US
  • World
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health
  • States
  • @
#EASD26: Lilly’s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes - Endpoints News
MMedication

#EASD26: Lilly’s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes – Endpoints News

  • October 4, 2026
  1. #EASD26: Lilly’s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes  Endpoints News
  2. Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s  CNBC
  3. Blockbuster retatrutide trial signals a ‘new high-water mark’ for weight-loss drugs  Scientific American
  4. Experimental Lilly combination drug tops Zepbound in weight-loss trial  Reuters
  5. ‘Godzilla’ of weight-loss drugs could provide other important health benefits  The Guardian
  • Tags:
  • CagriSema
  • Eloralintide
  • EloraTZP
  • Health
  • lilly
  • Medication
  • Obesity
  • r&d
  • retatrutide
  • tirzepatide
  • Type 2 diabetes
  • United States
  • UnitedStates
  • US
  • weight loss
  • Zepbound
United States
www.europesays.com